With the advent of MAAA, emerging evidence indicates that when certain combinations of biomarkers, such as the interferon signature and stem cell factor accompany autoantibody and ANA results, the predictive power for SLE is markedly increased (28). The gene discussed is BTG3; the disease is systemic lupus erythematosus.